Anzemet and Gastric ulcer - a phase IV clinical study of FDA data

Summary:

Gastric ulcer is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Aredia, and have Breast cancer.

The phase IV clinical study analyzes which people have Gastric ulcer when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Gastric ulcer?

Gastric ulcer (stomach ulcer) is found to be associated with 1,956 drugs and 3,380 conditions by eHealthMe. Check the latest studies of Gastric ulcer.

On Apr, 18, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 55 people (2.14%) have Gastric ulcer.

Among these 55 people:

How long have people been on Anzemet when they have Gastric ulcer? *

What is the gender of people who have Gastric ulcer when taking Anzemet? *

female: 86.54 %
male: 13.46 %

What is the age of people who have Gastric ulcer when taking Anzemet? *

What are other drugs people take besides Anzemet? *

What are other side effects people have besides Gastric ulcer? *

Nausea (feeling of having an urge to vomit): 45 people, 81.82%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 42 people, 76.36%
Nausea And Vomiting: 41 people, 74.55%
Intervertebral Disc Protrusion (spinal disc protrusion): 39 people, 70.91%
Diarrhea: 38 people, 69.09%
Pain In Jaw: 36 people, 65.45%
Abdominal Pain: 34 people, 61.82%
Anaemia (lack of blood): 34 people, 61.82%
Bone Disorder: 34 people, 61.82%
Injury: 34 people, 61.82%

What are the existing conditions these people have? *

Breast Cancer: 24 people, 43.64%
Discomfort: 22 people, 40.00%
Ovarian Cancer (cancer of ovary): 22 people, 40.00%
Neoplasm Malignant (cancer tumour): 22 people, 40.00%
Hot Flush (sudden feelings of heat): 22 people, 40.00%
Breast Cancer Metastatic: 22 people, 40.00%
Migraine (headache): 22 people, 40.00%
Granulocyte Count Decreased: 21 people, 38.18%
Metastases To Bone (cancer spreads to bone): 11 people, 20.00%
Multiple Myeloma (cancer of the plasma cells): 11 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Gastric ulcer?

- Check whether Gastric ulcer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Anzemet (2,603 reports)

Gastric ulcer treatments and more:

Gastric ulcer (113,573 reports)

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastric ulcer:

Gastric ulcer (1,956 drugs)

Browse all the conditions that are associated with Gastric ulcer:

Gastric ulcer (3,380 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.